Tarsus Pharmaceuticals, Inc.

TARS Financials — Income Statement, Margins & Balance Sheet

Revenue, net income, margins, cash and debt for TARS, built from reported filings and live market data.

$78.20-0.61% todayUSD · live quote
★ ZCoreAI PREMIUM7 days free

Unlock Full TARS Analysis

Explore Z-Score, Smart Money signals, all timeframes and Premium indicators for TARS.

✓Z-Score signals
✓Smart Money flow
✓All timeframes
✓Premium indicators
Start 7-Day Free Trial →

7-day free trial. No commitment during the trial.

TARS Income Statement (TTM)

$682.20M
Trailing twelve-month revenue reported by TARS.
Net income (TTM)
-$702.23M
EPS (TTM)
$-15.16
Gross margin
93.2%
Operating margin
-102.5%
Net margin
-102.9%
Revenue growth
+63.9%

TARS Revenue vs Net Income by Quarter

Light bars are revenue, solid bars are net income. The gap between them is the cost of running the business — when it narrows, margins are expanding.

Q4 2021 revenue $338000Q1 2022 revenue $539000Q1 2022 net income -$20.24MQ2 2022 revenue $15.28MQ2 2022 net income -$5.74MQ3 2022 revenue $0Q3 2022 net income -$22.51MQ2 2023 revenue $0Q3 2023 revenue $1.87MQ4 2023 revenue $13.08MQ1 2024 revenue $27.61MQ1 2024 net income -$35.73MQ4 2024 revenue $66.41MQ1 2025 revenue $78.33MQ1 2025 net income -$25.12MQ2 2025 revenue $102.66MQ2 2025 net income -$20.34MQ3 2025 revenue $118.70MQ3 2025 net income -$12.59MQ4 2025 revenue $151.67MQ4 2025 net income -$8.37MQ1 2026 revenue $162.05MQ1 2026 net income -$6.97MQ2 2026 revenue $173.91MQ2 2026 net income -$18.55MQ3 2026 revenue $194.57MQ3 2026 net income -$668.33M

TARS Financial Results by Period

The last 12 reported periods for TARS, most recent first.

PeriodRevenueNet incomeNet marginEPS
Q3 2026$194.57M-$668.33M-343.5%$-14.40
Q2 2026$173.91M-$18.55M-10.7%$-0.43
Q1 2026$162.05M-$6.97M-4.3%$-0.16
Q4 2025$151.67M-$8.37M-5.5%$-0.17
Q3 2025$118.70M-$12.59M-10.6%$-0.30
Q2 2025$102.66M-$20.34M-19.8%$-0.48
Q1 2025$78.33M-$25.12M-32.1%$-0.64
Q4 2024$66.41M——$-0.57
Q3 2024———$-0.61
Q2 2024———$-0.88
Q1 2024$27.61M-$35.73M-129.4%$-1.01
Q4 2023$13.08M——$-1.29

TARS Balance Sheet & Cash Generation

Cash, debt, share count and free cash flow — the inputs that decide whether TARS can fund growth without diluting shareholders.

Cash
$309.61M
Total debt
$72.94M
Net cash / (debt)
$236.68M
Shares outstanding
0.05B
Free cash flow
$69.01M
FCF yield
1.8%
Market cap
$3.86B
Price / sales
5.65x

Financials vs Valuation & Market Positioning

The statements tell you what the business earns; the multiples and Z-Score tell you what the market is currently charging for it.

Trailing P/E
—
Forward P/E
64.99
EPS growth
—
Revenue growth
+63.9%

Z-Score readings for TARS are not available right now.

How This TARS Financial Data Is Built

Revenue, net income and EPS come from TARS's reported filings through live ZCoreAI market endpoints. Trailing twelve-month figures sum the last four reported quarters, and net margin per period is net income divided by revenue for that same period. Gross and operating margins are taken from the reported profitability block.

Cash, debt and share count come from the latest published balance sheet; where a figure is absent, free cash flow is approximated from reported net income and shares are derived from market cap divided by price. Price to sales, FCF yield and the multiples use the live quote, so they update on every page load. Nothing here is investment advice.

TARS Financials FAQ

How much revenue does TARS generate?

TARS generated roughly $682.20M of revenue over the trailing twelve months, summed from the last four reported quarters.

Is TARS profitable?

TARS runs a -102.9% net margin, equal to -$702.23M of trailing net income.

Does TARS have too much debt?

TARS carries $72.94M of total debt against $309.61M of cash, a net cash position of $236.68M. Compare that against free cash flow of $69.01M to judge how quickly it could be repaid.

What is TARS's free cash flow?

TARS generates approximately $69.01M, a 1.8% yield on the current market cap. Free cash flow is what funds buybacks, dividends and debt repayment.

Where does ZCoreAI get TARS financial data?

Revenue, net income, EPS, margins and balance sheet items come from live ZCoreAI market endpoints sourced from company filings, refreshed on every page load.

TARS earnings

Quarterly EPS history, revenue trend and growth for TARS.

TARS P/E ratio

Trailing and forward multiples, PEG and earnings yield for TARS.

TARS forecast

DCF fair value, price prediction and signal targets for TARS.

TARS overview

Live chart, fundamentals and valuation context for TARS.

Research tools we use

  • Koyfin

    Financial data, screening and market research dashboards.

  • Stock Rover

    Stock screening and fundamental research for dividend and value investors.

Data refreshed from live ZCoreAI market endpoints. Informational only — not investment advice.